Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial - Pollock, KM; Cheeseman, HM; Szubert, AJ; Libri, V; Boffito, M; Owen, D; Bern, H; O'Hara, J; McFarlane, LR; Lemm, N-M; McKay, PF; Rampling, T; et al. (EClinicalMedicine, 2022)